Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rosenwirth

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|August 1, 1994
Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analogB Rosenwirth, A Billich, R Datema, et al.
Journal of Virology|April 3, 1998
T-cell lymphoma caused by herpesvirus saimiri C488 independently of ie14/vsag, a viral gene with superantigen homologyA Knappe, M Thurau, H Niphuis, et al.
The Journal of Experimental Medicine|March 10, 2001
Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologueA Ensser, D Glykofrydes, H Niphuis, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1994
Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100E De Clercq, N Yamamoto, R Pauwels, et al.
Journal of Virology|January 22, 2000
Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaquesB Rosenwirth, P ten Haaft, W M Bogers, et al.
Journal of Virology|November 23, 2000
Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicityD Glykofrydes, H Niphuis, E M Kuhn, et al.
Journal of Virology|June 17, 1998
The interleukin-17 gene of herpesvirus saimiriA Knappe, C Hiller, H Niphuis, et al.
Journal of Virology|September 5, 2001
Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359))L Holterman, R Dubbes, J Mullins, et al.
Journal of Medical Primatology|December 11, 1999
Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virusE J Verschoor, D Davis, M van Gils, et al.
Journal of Medical Primatology|December 11, 1999
An anti-HIV strategy combining chemotherapy and therapeutic vaccinationB Rosenwirth, W M Bogers, I G Nieuwenhuis, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|August 1, 1994
Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analogB Rosenwirth, A Billich, R Datema, et al.
Journal of Virology|April 3, 1998
T-cell lymphoma caused by herpesvirus saimiri C488 independently of ie14/vsag, a viral gene with superantigen homologyA Knappe, M Thurau, H Niphuis, et al.
The Journal of Experimental Medicine|March 10, 2001
Independence of herpesvirus-induced T cell lymphoma from viral cyclin D homologueA Ensser, D Glykofrydes, H Niphuis, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1994
Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100E De Clercq, N Yamamoto, R Pauwels, et al.
Journal of Virology|January 22, 2000
Antiretroviral therapy during primary immunodeficiency virus infection can induce persistent suppression of virus load and protection from heterologous challenge in rhesus macaquesB Rosenwirth, P ten Haaft, W M Bogers, et al.
Journal of Virology|November 23, 2000
Herpesvirus saimiri vFLIP provides an antiapoptotic function but is not essential for viral replication, transformation, or pathogenicityD Glykofrydes, H Niphuis, E M Kuhn, et al.
Journal of Virology|June 17, 1998
The interleukin-17 gene of herpesvirus saimiriA Knappe, C Hiller, H Niphuis, et al.
Journal of Virology|September 5, 2001
Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359))L Holterman, R Dubbes, J Mullins, et al.
Journal of Medical Primatology|December 11, 1999
Efforts to broaden HIV-1-specific immunity by boosting with heterologous peptides or envelope protein and the influence of prior exposure to virusE J Verschoor, D Davis, M van Gils, et al.
Journal of Medical Primatology|December 11, 1999
An anti-HIV strategy combining chemotherapy and therapeutic vaccinationB Rosenwirth, W M Bogers, I G Nieuwenhuis, et al.
Pageof 6